Clozapine for Cannabis Use in Schizophrenia
Public ClinicalTrials.gov record NCT01639872. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clozapine for Cannabis Use Disorder in Schizophrenia
Study identification
- NCT ID
- NCT01639872
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Enrollment
- 49 participants
Conditions and interventions
Interventions
- Clozapine Drug
- Risperidone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013
- Primary completion
- Mar 28, 2017
- Completion
- Mar 28, 2017
- Last update posted
- May 4, 2020
2013 – 2017
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CNS Network Inc | Garden Grove | California | 92845 | — |
| Pacific Research Partners | Oakland | California | 94607 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Unversity of Massachusetts Medical School | Worcester | Massachusetts | 01605 | — |
| Michigan State University / Cherry Street Health Services | Grand Rapids | Michigan | 49503 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| University of North Carolina/UNC Center for Excellence in Community Mental Health | Raleigh | North Carolina | 27610 | — |
| University of South Carolina | Columbia | South Carolina | 29203 | — |
| Rutland Regional Medical Center | Rutland | Vermont | 05701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01639872, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01639872 live on ClinicalTrials.gov.